Back to mobile site

Charles River Laboratorie (CRL) Misses Q1 EPS by 3c

April 29, 2015 4:36 PM EDT

Charles River Laboratorie (NYSE: CRL) reported Q1 EPS of $0.79, $0.03 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $320.4 million versus the consensus estimate of $324 million.

Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.60.

For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings